Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cipla Ltd. Regulatory Filings 2021

Sep 30, 2021

59275_rns_2021-09-30_3f5ea21a-4f3c-4ebb-9e87-3a393ab86cf3.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

30[th] September, 2021

(1) BSE Limited (2) National Stock Exchange of India Limited Listing Department, Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 Scrip Code: 500087 Scrip Code: CIPLA

  • (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Notice of the Board Meeting to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended 30[th] September, 2021

Dear Sir/Madam,

This is to inform you that meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 26[th] October, 2021 inter-alia to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended 30[th] September, 2021.

In terms of the Company’s Code of Conduct for Prevention of Insider Trading, the “Trading Window” for dealing in the securities of the Company will be closed from 1[st] October, 2021 till 28[th] October, 2021, for the purpose of financial results.

Thanking you

Yours faithfully, For Cipla Limited

RAJENDR Digitally signed by RAJENDRA A KUMAR KUMAR CHOPRA Date: 2021.09.30 CHOPRA 18:39:27 +05'30' Rajendra Chopra Company Secretary

Prepared by: Pratiksha Mangaonkar